Annals of Hematology

Papers
(The H4-Index of Annals of Hematology is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Refractory hepatosplenic T-cell lymphoma was successfully treated with salvage allogeneic hematopoietic stem cell transplantation combined with enhanced myeloablative preconditioning64
A case of acute promyelocytic leukemia with pericardial effusion successfully managed with colchicine during ATO administration62
Impact of race and ethnicity on outcomes after autologous stem cell transplantation for patients with newly diagnosed multiple myeloma60
Clonal evolution analysis of a rare acute promyelocytic leukemia patient transforming from essential thrombocythemia48
Germline mutations predispose a concurrent thymoma and diffuse large B-cell lymphoma42
Safe administration of venetoclax-obinutuzumab in a chronic lymphocytic leukemia patient with Brugada syndrome35
Optimizing hemophagocytic lymphohistiocytosis screening in children: validation of the HLH-Screen score35
Prognostic impact of TET2 mutations in patients with acute myeloid leukemia: HM-SCREEN-Japan 01 and 02 study34
Second allogeneic transplantation in relapsed acute leukemia – a risk worth taking?34
Prognostic significance of in patients with chronic lymphocytic leukemia: A meta-analysis33
Absence of blood donors’ anti-SARS-CoV-2 antibodies in pre-storage leukoreduced red blood cell units indicates no role of passive immunity for blood recipients32
Radiotherapy alone with curative intent in a case of limited-stage extranodal NK/T-cell lymphoma nasal type: a case report and review of the literature32
Outcome of patients with diffuse large B-cell lymphoma and testicular involvement – real world data29
Intramural esophageal hematoma precipitated by acquired factor XI deficiency in a patient with relapsed T cell prolymphocytic leukemia after allogeneic hematopoietic cell transplantation27
Symposium Proceedings of the international symposium ACUTE LEUKEMIAS XIX (ISALXIX), Munich March 16–19, 202525
Activity of trametinib as maintenance therapy after allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory RAS pathway-mutated hematologic malignancies25
Genetic variability profiling of the p53 signaling pathway in chronic lymphocytic leukemia. Individual and combined analysis of TP53, MDM2 and NQO1 gene variants24
Trimethoprim-sulfamethoxazole prevents interstitial pneumonitis in B-cell lymphoma patients receiving chemotherapy: a propensity score matching analysis24
Overview of 1q abnormalities in multiple myeloma: scientific opinions from Italian experts24
A nomogram model for predicting the efficacy of cyclosporine in patients with pure red cell aplasia23
Correction to: Hemophagocytic lymphohistiocytosis in HIV-associated lymphoproliferative disorders22
Whole-exome sequencing identifies FANC heterozygous germline mutation as an adverse factor for immunosuppressive therapy in Chinese aplastic anemia patients aged 40 or younger: a single-center retrosp22
0.14099907875061